Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Life Sciences, Medicine and Biomedicine is Scopus-indexed (Q3, CiteScore 0.6), DOAJ. Published by Biome Scientia Sdn Bhd.
Checked against the index lists dated .
ISSN 2600-7207Verify ISSN ↗
Publisher: Biome Scientia Sdn Bhd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 41 / 57 | 28th | Q3 |
| Medicine (miscellaneous) | 366 / 466 | 21st | Q4 |
| Drug Discovery | 147 / 161 | 9th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q3, CiteScore 0.6.
Life Sciences, Medicine and Biomedicine is Q3 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 41 of 57), Q4 in Medicine (miscellaneous) (rank 366 of 466) and Q4 in Drug Discovery (rank 147 of 161), by CiteScore 2025.
Life Sciences, Medicine and Biomedicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.6, quartile Q3, 28th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.113, quartile Q4, with an H-index of 3.
The publisher lists an article processing charge of about US$250 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Life Sciences, Medicine and Biomedicine is published by Biome Scientia Sdn Bhd. Its ISSN is 2600-7207.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Life Sciences, Medicine and Biomedicine has an h-index of 6 and a 2-year mean of 0.49 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q3. On 2-year citations it ranks #36 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Life Sciences, Medicine and Biomedicine published 10 papers in 2025; its busiest recent year was 2018 with 18. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 84 research articles (2021–2026), authors are most often from Malaysia (71.8%), Thailand (6.7%) and Philippines (4.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.